 Although indication of bicalutamide for the use was not granted, the bicalutamide medication label was updated to include the findings of the study.In terms of side effects, the combination of bicalutamide and anastrozole in the study was described as well tolerated with no safety concerns.However, gynecomastia, attributed to bicalutamide, was observed in almost half of the boys.